ArticleJournal of paediatrics and child health2026

Selumetinib as a Target Therapy in Progressive Paediatric Low-Grade Gliomas-Case Series (pLGG).

Laura Trapani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.